Retatrutide 10 mg

$49.90

Triple receptor agonist · GLP-1 / GIP / Glucagon · next-gen GLP

Specification: 10 mg / vial

Availability: Usually ships within 2 days.

Lab certificates

SKU: RET10 Category:
Research product information

Retatrutide 10 mg

Structured product, pathway, quality-documentation, and laboratory-handling information.

Product overview

Product
Retatrutide 10 mg
SKU
RET10
Compound
Retatrutide
Strength
10 mg / vial
Product format
Lyophilised peptide
Quantity per vial
10 mg
Stock
Availability shown at checkout

Compound profile

Receptor or pathway
GLP-1 / GIP / glucagon receptor agonism
Common areas of scientific investigation
  • Metabolic regulation studies
  • Body-weight and appetite signalling studies
  • Glucose and lipid pathway investigation
Known status
Investigational compound studied in ongoing clinical programmes.
Important limitations of available evidence
Long-term safety and durability data are still limited compared with older compounds in this class.

Quality documentation

Certificate reference
81055
Tested purity
See certificate
Testing method
See certificate
Testing laboratory
Janoshik
Test date
See certificate
Open certificate →

Storage and laboratory handling

Unopened storage
Follow supplier and batch-label storage instructions before opening.
Light exposure
Keep protected from direct light.
Temperature range
Use batch certificate and label conditions for temperature control.
Lyophilised
Yes
  • Use sterile laboratory technique.
  • Document lot, handling times, and storage conditions.

Recommended laboratory accessories

Description

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2/3 trials show superior weight reduction versus dual agonists. 10 mg research vial.

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 10 mg”

Your email address will not be published. Required fields are marked *